Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
07/2010
07/07/2010CN101768601A Method for producing recombinant human serum albumin-interferon alpha 2b
07/07/2010CN101768219A Recombinant fusion protein and preparing method and application thereof
07/07/2010CN101200503B Fusion protein for seralbumin and interferon
07/07/2010CN101182360B Fusion protein having antibiotic function and uses thereof
07/07/2010CN101037671B Hybridoma cell line and anti-human erythrocyte surface H antigen monoclonal antibodies generated thereof
07/06/2010US7750136 Using ribosome-inactivating protein (RIP)/cytotoxin fusion to target and destroy tumor cells
07/06/2010US7750133 Vascular endothelial cell growth inhibitor, VEGI-192a
07/06/2010US7750125 C35 tumor antigen specific monoclonal for use in diagnosis, prevention and treatment of cell proliferative disorders
07/06/2010US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators
07/06/2010US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta
07/06/2010US7749718 Method for raising or isolating an antibody to DCRS5
07/06/2010US7749514 Activatable clostridial toxins
07/06/2010US7749500 Antibodies to IL-17 polypeptides and therapeutic uses thereof
07/06/2010CA2209360C Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
07/01/2010WO2010074999A1 Hybrid alpha-amylases
07/01/2010WO2010074081A1 Protein substance having triple helix structure and manufacturing method therefor
07/01/2010WO2010073015A2 Peptide tag and uses thereof
07/01/2010WO2010071938A1 Novel collagen constructs
07/01/2010WO2010002478A3 Glycopeptide and uses thereof
07/01/2010US20100167393 Modified human thymic stromal lymphopoietin
07/01/2010US20100166792 Antigenic Polypeptides
07/01/2010US20100166761 Compositions and methods for the treatment of immune related diseases
07/01/2010CA2748015A1 Protein substance having triple helix structure and manufacturing method therefor
07/01/2010CA2746118A1 Hybrid alpha-amylases
06/2010
06/30/2010CN101759806A Cytoplasm leader peptide (CTD)-containing human epidermal growth factor fusion protein (CTD-hEGF) prepared by using hydroxylamine cutting method and application thereof
06/30/2010CN101759797A Phycocyanin beta subunits fluorescent protein combined with phycoerythrobilin PEB and application thereof
06/30/2010CN101759796A Allophycocyanin subunits fluorescent protein combined with phycocyanobilin PCB and application thereof
06/30/2010CN101759795A Molecular design phycoerythrocyanin beta subunit fluorescent protein combining phycocyanobilin (PCB) and application thereof
06/30/2010CN101759794A Molecular design phycoerythrocyanin beta subunit fluorescent protein combining phycoerythrobilin and application thereof
06/30/2010CN101759793A Phycocyanin and phycoerythrin alpha subunits fluorescent protein combined with phycoerythrobilin PEB and application thereof
06/30/2010CN101759792A Phycocyanin and phycoerythrin beta subunits fluorescent protein combined with phycocyanobilin PCB and application thereof
06/30/2010CN101759791A Phycocyanin and phycoerythrin beta subunits fluorescent protein combined with phycoerythrobilin PEB and application thereof
06/30/2010CN101759790A Allophycocyanin subunits fluorescent protein combined with phycoerythrobilin PEB and application thereof
06/30/2010CN101759789A Phycocyanin beta subunits fluorescent protein combined with phycocyanobilin PCB and application thereof
06/30/2010CN101759788A Molecular design phycocyanin beta subunit fluorescent protein combining phycocyanobilin and application thereof
06/30/2010CN101759787A Molecular design phycocyanin beta subunit fluorescent protein combining phycoerythrobilin and application thereof
06/30/2010CN101759786A Phycocyanin alpha subunits fluorescent protein combined with phycocyanobilin PCB and application thereof
06/30/2010CN101759785A Phycocyanin alpha subunits fluorescent protein combined with phycoerythrobilin PEB and application thereof
06/30/2010CN101070347B Bird-flu H5N1 novel mucous membrane immunization vaccine and its use
06/29/2010US7745406 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
06/29/2010US7745395 Recombinant protease comprising prostate-specific protease cleavage site and deficient in furin cleavage site for use as therapeutic agent in treatment of cell proliferative disorders; antitumor agents
06/29/2010US7745388 Peptide for use in the treatment of cell damage caused by ischemia
06/29/2010US7744903 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination; host cells
06/29/2010US7744878 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
06/29/2010CA2312188C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/29/2010CA2252372C Pathogenic escherichia coli associated protein
06/29/2010CA2134030C Soluble interferon .alpha.-receptor, its preparation and use
06/24/2010WO2010071769A2 Chimeric l. monocytogens in1b protein
06/24/2010WO2010071190A1 Heparin affinity erythropoietin
06/24/2010WO2010070453A2 Meningococcal vaccines including hemoglobin receptor
06/24/2010WO2010070137A1 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders
06/24/2010US20100160556 GLP-1 Fusion Peptides Conjugated to Polymer(s), Their Production and Use
06/24/2010US20100160174 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
06/24/2010US20100158911 Compositions and Methods of Treating Disease with FGFR Fusion Proteins
06/24/2010US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders
06/24/2010US20100158803 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
06/24/2010CA2747340A1 Meningococcal vaccines including hemoglobin receptor
06/24/2010CA2747065A1 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders
06/23/2010EP2199387A1 Serine protease derivatives and uses for the prevention and/or the treatment of blood coagulation disorders
06/23/2010EP2198890A1 Combinatorial libraries of monomer domains
06/23/2010EP2197909A2 Receptor-targeting reagents
06/23/2010EP2197903A1 Deletions in domain ii of pseudomonas exotoxin a that reduce non-specific toxicity
06/23/2010EP2197484A2 Compositions comprising pneumococcal antigens
06/23/2010EP1572748B1 Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2
06/23/2010CN1894275B Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
06/23/2010CN101747440A TNFR-Fc fusion protein and usage thereof
06/23/2010CN101747439A Combination of fusion protein for separating fluorescent protein, expression vector and application thereof
06/23/2010CN101747438A Combination of fusion protein for separating fluorescent protein, expression vector and application thereof
06/23/2010CN101747437A Apoptin-EC-SOD carboxyl terminal protein transduction domain fusion protein
06/23/2010CN101747414A Tumor necrosis factor (TNF)-alpha binding peptide and tumor necrosis factor receptor 1(TNFR1) blocking peptide and applications thereof in treatment of TNF related diseases
06/23/2010CN101747413A Envelope glycoprotein penetrating oligopeptide or modifier/ derivative thereof with blood platelet apoptosis activity inhibiting function and application
06/22/2010US7741446 Fusion antibodies that cross the blood-brain barrier in both directions
06/22/2010US7741439 Isolated stra6 polypeptides
06/22/2010US7741434 High-affinity antagonists of ELR-CXC chemokines
06/22/2010US7741286 kringle peptides; peptidase stabilized
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741115 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells
06/22/2010US7741064 biological reagents comprising the GPCR oligomers, methods of producing said biological reagents and assays for determining their function; determining compounds that have the ability to modulate the function of GPCR oligomers
06/22/2010US7741056 Junctional Adhesion Molecule (JAM); treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer; antagonist of a native sequence STIgMA polypeptide
06/22/2010US7740870 Group B Streptococcus antigens and corresponding DNA fragments
06/22/2010US7740853 Fcepsilon-pe chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same
06/22/2010US7740834 Murine zcytor17 ligand polypeptides
06/22/2010CA2454264C A method of producing insulinotropic glp-1 (7-36) polypeptide and/or glp-1 analogs
06/22/2010CA2216963C Tie-2 ligands, methods of making and uses thereof
06/22/2010CA2122745C Bifunctional glycoproteins having a modified carbohydrate complement, and their use in tumor-selective therapy
06/17/2010WO2010068278A2 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
06/17/2010WO2010067339A2 Fusion protein capable of binding vegf-a and tnf-alpha
06/17/2010WO2010066113A1 Composition of fusion proteins of split fluorescent proteins, expression vector, expression stable cell line, and screening method thereof
06/17/2010WO2010066090A1 Fusion proteins of apoptin-protein transduction domian of carboxyl-terminal end of ec-sod
06/17/2010WO2009158729A3 Compounds and methods for diagnosis and treatment of chagas disease
06/17/2010US20100150962 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
06/17/2010DE102008054494A1 New nucleic acid encoding a fusion protein that comprises specific amino acid sequences and a matrix-metalloprotease
06/16/2010CN1795203B Method for screening inhibitors of the gamma-secretase
06/16/2010CN1608129B Alkaline protease from bacillus sp. (DSM 14392) and uses thereof
06/16/2010CN1500095B Polymer conjugates of neublastin and methods of using ssame
06/16/2010CN1406249B Enhancing the circulating half-life of antibody-based fusion proteins
06/16/2010CN101743255A an anti-cancer cytotoxic monoclonal antibody
06/16/2010CN101743018A Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
06/16/2010CN101736006A Method for recombinant expression of soluble transcription mediator complex Med23 subunit
06/16/2010CN101735321A Polypeptide composition and application thereof in detecting tuberculosis antibody
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 295